In this episode, the discussants examines the following questions, raised after a Journal of Hepatology’s nomenclature article: Is the introduction of metabolic risk factors (MRF) for the definition of MASLD justified?What are the main issues regarding the measurement and thresholds for MRFs?Is the introduction of the MetALD category clinically justified?Is it necessary to worry about MRFs in a patient drinking increased or excessive amounts of alcohol and if yes, how should these be accounted for in disease classification systems?Faculty Vlad Ratziu (Moderator)Giulio Marchesini (Faculty)Nancy Reau (Faculty)Roberto Vettor (Faculty)Related article A multi-society Delphi consensus statement on new fatty liver disease nomenclatureRelated episodes EASL Studio from EASL Congress 2023: Steatotic liver disease global consensus to change nomenclatureAll EASL Studio Podcasts are available on EASL Campus.